Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Cervical Cancer Clinical Trials

116 recruiting trials for Cervical Cancer. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
116
Total Trials
116
Recruiting Now
8
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGPhase 1 / Phase 2NCT06022757

Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed...

In this study, participants with different types of advanced solid tumors who failed standard treatments will be treated with XNW5004 in combination with KEYTRUDA® (pembrolizumab)...

Sponsor: Evopoint Biosciences Inc.Enrolling: 2041 location
RECRUITINGNCT06440018

INSPIRE: a Multi-Cancer Early Detection Study

This research constitutes a multi-centric, case-control designed investigation aimed at developing and implementing a blinded validation of a machine learning-powered,...

Sponsor: Singlera Genomics Inc.Enrolling: 53501 location
RECRUITINGNCT05912972

Development and Management of Registry in Patients With Gynecologic Cancer in Korea

The goal of this observational study is to identify and analyze the characteristics, treatment trends, prognostic factors and survival prognosis of Korean gynecologic cancer...

Sponsor: Asan Medical CenterEnrolling: 135001 location
RECRUITINGNCT06339827

ASk Questions in GYnecologic Oncology (ASQ-GYO)

The goal of this clinical trial is to determine the effectiveness of the ASk Questions in GYnecologic Oncology question prompt list (ASQ-GYO QPL) at improving patient...

Sponsor: Ira WinerEnrolling: 701 location
RECRUITINGPhase 1 / Phase 2NCT06265025

GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors

The purpose of this study is to measure safety, tolerability, and preliminary antitumor efficacy of GM103 administered alone and in combination with pembrolizumab in patients with...

Sponsor: GeneMedicine Co., Ltd.Enrolling: 1254 locations
RECRUITINGPhase 1 / Phase 2NCT06814496

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

Phase I study to examine safety of the addition of concurrent tarlatamab with standard palliative and consolidative RT regimens , with a main cohort of N=20-24 patients with...

Sponsor: University of ArizonaEnrolling: 301 location
RECRUITINGPhase 2NCT06630611

Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After...

Background: The presence of T-lymphocytes in resected tumor samples derived from long-term survival patients and the fact that reinvigoration of their functionality through the...

Sponsor: Vall d'Hebron Institute of OncologyEnrolling: 401 location
RECRUITINGPhase 1 / Phase 2NCT05086692

A Beta-only IL-2 ImmunoTherapY Study

This is a Phase 1/2, multi-center, open-label, dose-escalation and expansion study to evaluate safety and tolerability, PK, pharmacodynamic, and early signal of anti-tumor...

Sponsor: Medicenna Therapeutics, Inc.Enrolling: 11520 locations
RECRUITINGPhase 1NCT04038619

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary...

This trial studies how well fecal microbiota transplantation works in treating diarrhea or colitis (inflammation of the intestines) that is caused by certain types of medications...

Sponsor: M.D. Anderson Cancer CenterEnrolling: 401 location
RECRUITINGNCT06004011

AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)

Adolescents and young adults living with HIV experience higher premature mortality from cancer than their uninfected peers. In Zambia, because of multilevel barriers,...

Sponsor: ImplenomicsEnrolling: 41001 location
RECRUITINGNCT07227077

Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial

The purpose of this study is to assess the best time to deliver a message to increase physical activity and how often participants will experience a pain episode in the 24 hours...

Sponsor: Medical College of WisconsinEnrolling: 501 location
RECRUITINGPhase 1 / Phase 2NCT07433283

Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor

Independently developed by Sichuan Yingrui Pharmaceutical Technology Co., Ltd., CNSI-Fe is an innovative anti-cancer drug with Fe2+ as the active ingredient, which exerts...

Sponsor: Sichuan Enray Pharmaceutical Sciences CompanyEnrolling: 549 locations
RECRUITINGPhase 1 / Phase 2NCT06239194

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

This study is designed to characterize the safety, tolerability, and anti-tumor activity of MDX2001 in patients with advanced solid tumors.

Sponsor: ModeX Therapeutics, An OPKO Health CompanyEnrolling: 1156 locations
RECRUITINGNCT04916990

Improving Care for Rural Patients With Solid Tumors

This study will assess if the CARES (Cancer Advocacy, Resources, Education and Support) intervention improves time to start of treatment after diagnosis and time to treatment...

Sponsor: University of Colorado, DenverEnrolling: 32014 locations
RECRUITINGNCT06431100

a Single-arm, Single-center, Open Clinical Study

This trial plans to enroll many patients with advanced solid tumors to complete GK01 cell transfusion, including but not limited to advanced gastric cancer, esophageal cancer,...

Sponsor: Beijing Geekgene Technology Co., LTDEnrolling: 101 location
RECRUITINGPhase 1NCT05983432

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

The objective of this study is to evaluate the safety, tolerability, and efficacy of BL-B01D1 in patients with Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and...

Sponsor: SystImmune Inc.Enrolling: 47020 locations
RECRUITINGNCT06729762

Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules

To evaluate long-term outcomes of ultrasound-guided thermal ablation for benign thyroid nodules

Sponsor: Chinese PLA General HospitalEnrolling: 15001 location
RECRUITINGNCT07359586

Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia

This study retrospectively analyzed patients who underwent tracheal intubation under general anesthesia at the First Affiliated Hospital of Zhejiang University School of Medicine...

Sponsor: Zhejiang UniversityEnrolling: 12002 locations
RECRUITINGPhase 2NCT06378177

A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)

The purpose of this study is to assess the safety and efficacy of LVGN6051 (4-1BB agonistic antibody) combined with toripalimab (anti-PD-1 antibody) and paclitaxel (anti-tubulin...

Sponsor: Lyvgen Biopharma Holdings LimitedEnrolling: 6417 locations
RECRUITINGNCT06645951

Institution of an Italian Multicenter Database of Patients with Parathyroid Carcinoma or Atypical Parathyroid Adenoma

The goal of this observational study is to create, manage and analyze a multicenter national database of patients with parathyroid carcinoma or atypical parathyroid adenoma, aimed...

Sponsor: F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo SettoreEnrolling: 30020 locations
RECRUITINGNCT06297902

RAdiotherapy With FDG-PET Guided Dose-PAINTing Compared With Standard Radiotherapy for Primary Head and Neck Cancer-3

The objective of the RADPAINT-3 trial is to investigate whether dose painting is safe compared to standard radiotherapy. RADPAINT-3 is a randomized, non-inferiority, multi-center...

Sponsor: Oslo University HospitalEnrolling: 1003 locations
RECRUITINGNCT04449445

Perioperative Nutritional Optimization in Head and Neck Cancer Patients

To determine whether nutritional optimization in head and neck cancer patients undergoing major surgery will decrease post-operative wound complications. The Investigators...

Sponsor: University of Illinois at ChicagoEnrolling: 3001 location
RECRUITINGPhase 2NCT06693323

Single-Center Eval of Clinical & Radiological Benefit AHCC in Combo W/ SOC Tx for HPV+ Pts W/ HNSCC

This is a phase 2, single-arm, open-label clinical trial determining safety and tolerability of AHCC in subjects with HPV-positive patients with Head and Neck Squamous Cell...

Sponsor: University of California, IrvineEnrolling: 341 location
RECRUITINGNCT05638269

A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China

The human gut microbiome has been associated with many health factors but variability between studies limits the exploration of effects between them. This study aims to...

Sponsor: Zhujiang HospitalEnrolling: 1200020 locations
RECRUITINGNCT06037902

CPAP for Esophageal Cancer With Radiotherapy

The goal of this clinical trial is to test the use of CPAP in patients with esophgaeal cancer undergoing radiotherapy. The main questions it aims to answer are: * does use of...

Sponsor: Sheba Medical CenterEnrolling: 441 location
RECRUITINGPhase 2NCT06970353

Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer

This phase II trial evaluates Tunlametinib (MEK inhibitor) ± PD-1 in NRAS-mutant advanced thyroid cancer. Key Objectives: Assess efficacy (ORR by RECIST v1.1) Evaluate safety...

Sponsor: Fudan UniversityEnrolling: 401 location
RECRUITINGNCT06346080

Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment

The goal of this survey is to investigate the participants' preference for a specific screening/diagnostic tool to detect and assess gastro-esophageal cancer. The main question...

Sponsor: KU LeuvenEnrolling: 22001 location
RECRUITINGNCT05314946

Nutritional Support During Induction Therapy for Esophageal Cancer

Patients diagnosed with esophageal cancer have difficulty eating, as the food pipe becomes obstructed by the cancer. This may impair the ability for the patient to receive...

Sponsor: Mehdi QiabiEnrolling: 261 location
RECRUITINGNCT04981119

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Objective: To collect information on how often a solid tumor cancer might lose the Human Leukocyte Antigen (HLA) by next generation sequencing and perform apheresis to collect...

Sponsor: A2 Biotherapeutics Inc.Enrolling: 20016 locations
RECRUITINGNCT01958762

Screening for Cancers in the Oral CAvity

In the Somme region of France, cancer registry data showed an increasing incidence of oral cancer. The Incidence Rates in Somme as compared to the national rates for Lip, Oral...

Sponsor: Centre Hospitalier Universitaire, AmiensEnrolling: 1002 locations
RECRUITINGNCT06791941

Study of the Contribution of Mutant p53/YAP Proteins to Therapy Resistance in Recurrent Head and Neck Cancer

Multicenter, non-interventional, retrospective/prospective study of a biological nature, on patients affected by head and neck tumors, for which the collection and use of tissue...

Sponsor: Regina Elena Cancer InstituteEnrolling: 181 location
RECRUITINGNCT06463756

AI Models to Predict Thyroid Cartilage Invasion in Laryngeal Carcinoma

This retrospective study was to develop and verify CT-based AI model to preoperatively predict the thyroid cartilage invasion of laryngeal cancer patients, so as to provide more...

Sponsor: First Affiliated Hospital of Chongqing Medical UniversityEnrolling: 4001 location
RECRUITINGPhase 1 / Phase 2NCT06710756

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Phase I/IIa image-guided, alpha-particle therapy study of \[203Pb\]Pb-PSV359 and \[212Pb\]Pb-PSV359 in patients with solid tumors that are known to be Fibroblast Activation...

Sponsor: Perspective TherapeuticsEnrolling: 1123 locations
RECRUITINGNCT02435576

Standard Follow-up Program (SFP) for Head and Neck Cancer Patients

The primary and general objective of the clinical introduction of the SFP as the current standard of care is to improve the quality of radiotherapy for head and neck cancer...

Sponsor: University Medical Center GroningenEnrolling: 100001 location
RECRUITINGNCT06836869

Modified Tumor-free Techniques Operation to Cervical Cancer

The goal of this clinical trial is to learn if laparoscopic radical hysterectomy incorporating modified tumor-free techniques (LRH-MTF) works to treat FIGO stage IB2 cervical...

Sponsor: Peking Union Medical College HospitalEnrolling: 52417 locations
RECRUITINGPhase 2NCT07007364

Neoadjuvant Low-Dose Radiotherapy Combined With Adebrelimab and Single-Agent Albumin-Bound Paclitaxel Chemotherapy for...

This is a prospective, single-arm, Phase II clinical trial. The included population consisted of untreated patients with histologically confirmed stage I-II oral squamous cell...

Sponsor: Jun JiaEnrolling: 301 location
RECRUITINGNCT07196033

Asian Gynecological Brachytherapy Registry in Cervical Cancer

Gynecological cancer poses as significant public health issue, especially in Asian countries, where it is a leading cause of cancer-related deaths among women. Cervical cancer...

Sponsor: Tata Memorial HospitalEnrolling: 10005 locations
RECRUITINGPhase 2NCT05343325

The Efficacy and Safety of Neoadjuvant Low-dose Radiotherapy Combined With Chemoimmunotherapy in Locally Advanced HNSCC

This is an open-label, single-arm, phase II clinical trial to explore the efficacy and safety of neoadjuvant low-dose radiotherapy combined with chemoimmunotherapy in resectable...

Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen UniversityEnrolling: 252 locations
RECRUITINGNCT06550050

Clinical and Molecular Features of Oral Premalignancy and Oral Cancer

Investigators will employ serial assessments of tissue biopsy and additional biomarkers that reflect burden of disease and predict treatment response. Patients enrolled on this...

Sponsor: M.D. Anderson Cancer CenterEnrolling: 10001 location
RECRUITINGNCT07215169

Manual Lymph Drainage for External Lymphedema

This study will evaluate the feasibility of a randomized controlled trial. The future randomized controlled trial will compare two groups following different intensities of manual...

Sponsor: Lund UniversityEnrolling: 401 location
RECRUITINGPhase 2NCT06155396

A Study of RC48-ADC Combination With Zimberelimab Injection Therapies at Least First-line Platinum-containing Standard...

This study will evaluate the efficacy,safety of RC48-ADC in Combination with Zimberelimab Injection for the Treatment ,at least first-line platinum-containing standard therapy...

Sponsor: RemeGen Co., Ltd.Enrolling: 11612 locations
RECRUITINGPhase 3NCT04453826

Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma

Through multicenter, open-label, randomised clinical trials, we intend to demonstrate that concurrent and adjuvant PD-1 treatment added to chemo-radiotherapy could further...

Sponsor: Sun Yat-sen UniversityEnrolling: 3886 locations
RECRUITINGPhase 2NCT06769113

A Phase II Clinical Study to Evaluate HLX43 in Patients With Recurrent/Metastatic ESCC Failed or Intolerance to...

The study is being conducted to explore the reasonable dosage and evaluate the efficacy, safety and tolerability of HLX43 (Anti-PD-L1 ADC) in Patients with Recurrent/Metastatic...

Sponsor: Shanghai Henlius BiotechEnrolling: 721 location
RECRUITINGPhase 1NCT04119024

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic...

This phase I trial studies the side effects and best dose of modified immune cells (IL13Ralpha2 CAR T cells) after a chemotherapy conditioning regimen for the treatment of...

Sponsor: Anusha KalbasiEnrolling: 183 locations
RECRUITINGPhase 2NCT06064097

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

This phase II trial tests effects of nivolumab in combination with chemotherapy drugs prior to radiation therapy patients with nasopharyngeal carcinoma (NPC). Immunotherapy with...

Sponsor: National Cancer Institute (NCI)Enrolling: 5020 locations
RECRUITINGPhase 2NCT06869213

A Single-arm, Open, Single-center Exploratory Study of Adebrelimab (SHR-1316) in Combination With Chemotherapy for the...

This study is a prospective, observational clinical study. In this study, 30 patients with resectable locally advanced esophageal squamous carcinoma will be prospectively enrolled...

Sponsor: Peking University Cancer Hospital & InstituteEnrolling: 301 location
RECRUITINGPhase 4NCT07189897

Apixaban or Enoxaparin After Head and Neck Cancer Surgery

The goal of this clinical trial is to learn if apixaban (a pill) is a safe and easier alternative to taking enoxaparin (a daily shot) to prevent blood clots after head and neck...

Sponsor: Kiranya ArnoldEnrolling: 761 location
RECRUITINGNCT07305727

A Radiomic MRI Predictive Model for Response to Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer

Cervical cancer is the fourth most common cancer in women worldwide, with approximately 604,000 new cases in 2020.Treatment for locally advanced cervical cancer is based on a...

Sponsor: Centre Hospitalier Universitaire de NīmesEnrolling: 1201 location
RECRUITINGNCT07110142

Tongue Proactive Strengthening Exercise Program Following Partial/Hemi Glossectomy and Reconstruction

This study is being done to determine whether adding a proactive tongue strengthening exercise program using a biofeedback device (the Tongueometer) improves speech and swallowing...

Sponsor: Case Comprehensive Cancer CenterEnrolling: 401 location
RECRUITINGNCT06253169

HPV DNA Self-sampling in a General Practitioner's Office.

One of the limitations of organized cervical screening in the Czech Republic is the lack of participation in preventive gynecological examinations. The aim of the project is to...

Sponsor: Patient Organization VeronicaEnrolling: 20002 locations

Showing 50 of 116 trials.Search all Cervical Cancer trials